Report: Opdivo set to have biggest share in renal cell carcinoma market by 2023

Opdivo is projected to lead the growth in renal cell carcinoma (RCC) market and be a market leader by 2023, according to a report by GlobalData.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news